Molecular epidemiology of HIV-1 subtype B, CRF01-AE, and CRF07-BC infection among injection drug users in Taiwan

Journal of Acquired Immune Deficiency Syndromes

Volumn 53, Issue 4, 2010, Pages 425-439

  Chen, Yen Ju ^a   Huang, Yu Huei ^a   Chuang, Shao Yuan ^b   Kao, Diana Yu Ting ^a   Lan, Yu Ching ^c   Yang, Jyh Yuan ^d   Chen, Yi Ming Arthur ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d Centers for Disease Control   (Taiwan)

Author keywords

CRF01 AE; CRF07 BC; HIV; Injection drug users; Risk factors; Sharing dissolved heroine solution; Sharing syringes

Indexed keywords

DIAMORPHINE;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PRISON; QUESTIONNAIRE; RISK FACTOR; SYRINGE;

ADULT; CASE-CONTROL STUDIES; DRUG USERS; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLYMERASE CHAIN REACTION; PRISONERS; RISK FACTORS; SEQUENCE ANALYSIS, DNA; SUBSTANCE ABUSE, INTRAVENOUS; TAIWAN; YOUNG ADULT;

EID: 77949401135     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181ccba1a     Document Type: Article

References (52)

1. World Drug Report 2006. p. 8. The United Nations International Drug Control Programme. Available at: http://www.unodc.org/pdf/WDR-2006/wdr2006- volume1.pdf.
2. Ministry of Justice, R.O.C. (Taiwan). Justice Data. Available at: http://www.moj.gov.tw. Accessed June 20, 2006.
3. Koester S, Heimer R, Baron AE, et al. Risk of hepatitis C virus among young adult injection drug users who share injection equipment. Am J Epidemiol. 2003;157:376; author reply 376-378.
4. Schoenbaum EE, Hartel D, Selwyn PA, et al. Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med. 1989;321:874-879.
5. Chaisson RE, Moss AR, Onishi R, et al. Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. Am J Public Health. 1987;77:169-172.
6. Jose B, Friedman SR, Neaigus A, et al. Syringe-mediated drug-sharing (backloading): a new risk factor for HIV among injecting drug users. AIDS. 1993;7:1653-1660.
7. Samuels J, Vlahov D, Anthony JC, et al. The practice of frontloading among intravenous drug users: associations with HIV antibody. AIDS. 1991;5:343.
8. Marmor M, Des Jarlais DC, Cohen H, et al. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS. 1987;1:39-44.
9. Wiebel WW, Jimenez A, Johnson W, et al. Risk behavior and HIV seroincidence among out-of-treatment injecting drug users: a four-year prospective study. JAcquir Immune Defic Syndr Hum Retrovirol. 1996;12: 282-289.
10. Vlahov D, Khabbaz RF, Cohn S, et al. Incidence and risk factors for human T-lymphotropic virus type II seroconversion among injecting drug users in Baltimore, Maryland, U.S.A. J Acquir Immune Defic Syndr Human Retrovirol. 1995;9:89-96.
11. Thorpe LE, Ouellet LJ, Hershow R, et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol. 2002;155:645-653.
12. Hagan H, Thiede H, Weiss NS, et al. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health. 2001;91: 42-46.
13. Beyrer C. HIV epidemiology update and transmission factors: risks and risk contexts\16th International AIDS Conference Epidemiology Plenary. Clin Infect Dis. 2007;44:981-987.
14. Santibanez SS, Garfein RS, Swartzendruber A, et al. Update and overview of practical epidemiologic aspects of HIV/AIDS among injecting drug users in the United States. J Urban Health. 2006;83:86-100.
15. Center for Disease Control, R.O.C. (Taiwan). HIV/AIDS Data. Available at: http://www.cdc.gov.tw/en/index asp. Accessed May 9, 2006.
16. Chen YM, Kuo SH. HIV-1 in Taiwan. Lancet. 2007;369:623-625.
17. Chen YM, Lan YC, Lai SF, et al. HIV-1 CRF07-BC infections, injecting drug users, Taiwan. Emerg Infect Dis. 2006;12:703-705.
18. Lin YT, Lan YC, Chen YJ, et al. Molecular epidemiology and full-length genomic analysis of HIV-1 circulating recombinant form 07-BC strains from injecting drug users in Taiwan. J Infect Dis. 2007;195:1283-1293.
19. Wei M, Guan Q, Liang H, et al. Simple subtyping assay for human immunodeficiency virus type 1 subtypes B, C, CRF01-AE, CRF07-BC, and CRF08-BC. J Clin Microbiol. 2004;42:4261-4267.
20. Kumar S, Tamura K, Nei M. MEGA3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform. 2004;5:150-163.
21. Felsenstein J. Using the quantitative genetic threshold model for inferences between and within species. Philos Trans R Soc Lond B Biol Sci. 2005;360:1427-1434.
22. Parthasarathy S, Ravishankar M. HIV and anaesthesia. Indian J Anaesth. 2007;51:91-99.
23. Shah SM, Shapshak P, Rivers JE, et al. Detection of HIV-1 DNA in needles/syringes, paraphernalia, and washes from shooting galleries in Miami: a preliminary laboratory report. J Acquir Immune Defic Syndr Human Retrovirol. 1996;11:301-306.
24. Chen CH, Yang PM, Huang GT, et al. Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. J Formosan Med Assoc. 2007;106: 148-155.
25. Garfein RS, Vlahov D, Galai N, et al. Viral infections in short-term injecting drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health. 1996;86:655-661.
26. Garten RJ, Lai S, Zhang J, et al. Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. Int J Epidemiol. 2004;33:182-188.
27. Lee YM, Lin HJ, Chen YJ, et al. Molecular epidemiologyofHCV genotypes among injection drug users in Taiwan: full-length sequences of two new subtype 6w strains and a recombinant form-2b6w. J Med Virol. In press.
28. Choi SY, Cheung YW, Chen K. Gender and HIV risk behavior among intravenous drug users in Sichuan Province, China. Soc Sci Med. 2006;62: 1672-1684.
29. Riehman KS, Kral AH, Anderson R, et al. Sexual relationships, secondary syringe exchange, and gender differences in HIV risk among drug injectors. J Urban Health. 2004;81:249-259.
30. Watters JK. Trends in risk behavior and HIV seroprevalence in heterosexual injecting drug users in San Francisco, 1986-1992. J Acquir Immune Defic Syndr. 1994;7:1276-1281.
31. Colon HM, Sahai H, Robles RR, et al. Effects of a community outreach program in HIV risk behaviors among injection drug users in San Juan, Puerto Rico: an analysis of trends. AIDS Educ Prev. 1995;7: 195-209.
32. Des Jarlais DC, Hagan H, Friedman SR, et al. Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA. 1995;274: 1226-1231.
33. Holtgrave DR, Qualls NL, Curran JW, et al. An overview of the effectiveness and efficiency of HIV prevention programs. Public Health Rep. 1995;110:134-146.
34. Hunter GM, Donoghoe MC, Stimson GV, et al. Changes in injecting risk behavior of injecting drug users in London, 1990-1993. AIDS. 1995;9: 493-501.
35. Nicolosi A, Molinari S, Musicco M, et al. Positive modification of injecting behavior among heroin users from Milan and Northern Italy 1987-1989. Br J Addict. 1991;86:91-102.
36. Stephens RC, Feucht TE, Roman SW. Effects of an intervention program on AIDS-related drug and needle behavior among intravenous drug users. Am J Public Health. 1991;81:568-571.
37. Koester S, Booth S, Zhang Y. The prevalence of additional injection-related HIV risk behaviors among injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;12:202-207.
38. Tortu S, Deren S, Beardsley M. Factors associated with needle exchange use in East Harlem, New York City. J Drug Issues. 1996;26: 735-749.
39. Bluthenthal RN, Kral AH, Erringer EA, et al. Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992 to 1995. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18:505-511.
40. Koester SK, Hoffer L. "Indirect sharing": additional risks associated with drug injection. AIDS Public Policy J. 1994;3:100-105.
41. Heroin: Just the Facts. Available at: http://www.ireta.org/opiates2005/ 09.pdf.
42. Beyrer C, Sripaipan T, Tovanabutra S, et al. High HIV, hepatitis C and sexual risks among drug-using men who have sex with men in northern Thailand. AIDS. 2005;19:1535-1540.
43. Ferreira AD, Caiaffa WT, Bastos FI, et al. Profile of male Brazilian injecting drug users who have sex with men. Cad Saude Publica. 2006;22: 849-860.
44. Scopolamine PoisoningAmong Heroin Users\New York City, Newark, Philadelphia, and Baltimore, 1995 and 1996. Morbidity and Mortality Weekly Report 1996, 45. Available at: http://www.health.org/pressrel/cdcre.htm or http://www.cdc.gov/epo/mmwr/mmwr-wk.html.
45. Ramos R. An Ethnographic Study of Heroin Abuse by Mexican Americans in San Antonio, Texas. TCADA Research Briefs 1997. Austin, TX: Texas Commission on Alcohol and Drug Abuse. Available at: http://www.tcada.state.tx.us/research/ research.html.
46. Su L, Graf M, Zhang Y, et al. Characterization of a virtually full-length human immunodeficiency virus type 1 genome of a prevalent intersubtype (C/B') recombinant strain in China. J Virol. 2000;74:11367-11376.
47. BeyrerC,Razak MH, LisamK, et al. Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia. AIDS. 2000;14:75-83.
48. Gao F, Robertson DL, Morrison SG, et al. The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J Virol. 1996;70: 7013-7029.
49. Chen YM, Lee CM, Lin RY, et al. Molecular epidemiology and trends of HIV-1 subtypes in Taiwan. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;19:393-402.
50. Nguyen L, Hu DJ, Choopanya K, et al. Genetic analysis of incident HIV-1 Strains among injection drug users in Bangkok: evidence for multiple transmission clusters during a period of high incidence. J Acquir Immune Defic Syndr. 2002;30:248-256.
51. Laeyendecker O, Zhang GW, Quinn TC, et al. Molecular epidemiology of HIV-1 subtypes in Southern China. J Acquir Immune Defic Syndr. 2005; 38:356-362.
52. Piyasirisilp S, McCutchan FE, Carr JK, et al. A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant. J Virol. 2000;74: 11286-11295.